Seoul, South Korea

Jong Keun Jeong


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal1 out of 833,002 
Other
 patents

Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Gene Therapy by Jong Keun Jeong

Introduction

Jong Keun Jeong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of gene therapy, particularly in the development of novel hepatitis B virus vectors. His work aims to enhance therapeutic options for liver diseases and genetic disorders.

Latest Patents

Jong Keun Jeong holds a patent for "Hepatitis B virus vectors for gene therapy." This invention relates to innovative hepatitis B virus vectors designed to deliver therapeutic genes specifically to liver cells. The recombinant viruses produced through this invention can be utilized in both in vivo and ex vivo therapy protocols. This technology not only addresses liver diseases but also has potential applications in treating various genetic disorders.

Career Highlights

Throughout his career, Jong Keun Jeong has focused on advancing gene therapy techniques. His research has led to the development of methods for producing recombinant hepatitis B viruses, which are crucial for effective gene delivery. His innovative approach has positioned him as a key figure in the field of biotechnology.

Collaborations

Jong Keun Jeong has collaborated with notable professionals in his field, including Wang-Shick Ryu and Jehan Lee. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Jong Keun Jeong's work in gene therapy represents a significant advancement in medical science. His innovative hepatitis B virus vectors offer promising solutions for treating liver and genetic diseases. His contributions continue to influence the field and pave the way for future research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…